American Medical Technologies, Inc. Makes Announcement.Business Editors, Health/Medical Writers CORPUS CHRISTI, Texas--(BUSINESS WIRE)--Nov. 6, 2002 American Medical Technologies, Inc. ("AMT See vPro. ") announced that Biolase Technologies, Inc. has filed a patent infringement patent infringement n. the manufacture and/or use of an invention or improvement for which someone else owns a patent issued by the government, without obtaining permission of the owner of the patent by contract, license or waiver. lawsuit against it in Federal District Court for the Central District of California. The lawsuit alleges, among other things, that the Company's Cavilase laser, which is under development, infringes one or more Biolase patents. The suit seeks, among other things, injunctive relief injunctive relief n. a court-ordered act or prohibition against an act or condition which has been requested, and sometimes granted, in a petition to the court for an injunction. and an unspecified amount of actual and trebled damages. "Having just received the complaint, we and our attorneys are studying the Biolase claims to formulate appropriate legal and business responses to the lawsuit," stated Roger Dartt, Chairman. "We certainly intend to vigorously defend the lawsuit." American Medical Technologies, Inc. headquartered in Corpus Christi, Texas Corpus Christi is a coastal city and the county seat of Nueces CountyGR6 in the U.S. state of Texas. It is part of the region known as South Texas. , develops and manufactures advanced technologies for dentistry and markets them worldwide. It is listed on the NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on SmallCap Market under the symbol "ADLI". The Company's website is found at: www.americanmedicaltech.com |
|
||||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion